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Abstract: The activation of certain cells, such as fibroblasts, with the appearance of
cancer has been studied and established. In order to accelerate and cheapen breast
cancer diagnosis the optimisation of machine learning algorithms can be a powerful tool.
Using two different data sets we studied the performance of different machine learning
algorithms. We also studied the relevance of the different studied parameters, which
could lead to some relevant biomedical conclusions. Further, we discuss the results
obtained and discuss key aspects for improving the analysis of such experiments, as
well as future directions for the use of Machine Learning in research against cancer.
I. INTRODUCTION
According to the ”American Cancer Society” 1 in ev-
ery 8 women suffer from breast cancer at some point of
their lives [1]. World Health Organisation (WHO) stated
that 2.3 million women were diagnosed with breast can-
cer and 685,000 died globally in 2020[2]. Breast cancer
is the most prevalent in the world, and it affects people,
specially women, at any age after puberty, even though
the rates increase in older people.
Breast cancer arises in the glandular tissue, and it
is initially innocuous. The uncontrolled growth of can-
cerous cells may progress and affect surrounding tissues
and eventually be transmitted to blood vessels spread it
throughout the body, affecting other organs. Women who
die from breast cancer, do so because metastasis affects
organs other than breast tissue, therefore identifying it
in early stages and avoiding its spread is vital.
In effect, high-income countries where detection and
treatment are more accessible to everyone the survival
rates for at least 5 years after diagnosis are around 90%,
whereas less developed countries have a survival rate of
around 40%.
A. Cancer associated fibroblasts (CAFs)
Fibroblasts are non-specialised cells that form the con-
nective tissue, present in most organs in the human body.
Fibroblasts are normally non-active but they are capable
of responding to tissue injury if activated; they play a
main role in generating scar tissue. When normal fibrob-
lasts are activated by tumour cells, they become either
tumour-suppressing CAF or tumour-promoting CAF [3].
Fibroblasts also support the tissue function by regulat-
ing the extracellular matrix, by secreting fibrous proteins
that form a supportive network reinforcing cell adhesion,
proliferation and migration.
Numerous studies support that fibroblasts are associ-
ated with cancer cells at all the stages of cancer growth
and play a main role for its spread or metastasis [4].
Therefore the presence of activated fibroblasts can be an
indication to the presence of cancerous cells.
Among other functions tumour-promoting CAFs help
remodel and regenerate cancerous tissue and support tu-
mour growth, invasion of surrounding tissue and metas-
tasis.
There are also some studies that support that, despite
the evidence of the tumour-promoting role of the CAFs,
fibroblasts are also involved in tumour suppression.
B. Machine Learning as a tool for research
Machine Learning (ML) relies on algorithms to anal-
yse big datasets. Currently, Machine Learning has al-
ready earned a position in many fields, also in scien-
tific research. ML is very useful as it is able to evolve
and adapt new circumstances much faster than a human
mind can. Algorithms detect patterns in a data source
create behaviours based on the recognised patterns and
make decisions based on the success or failure of its train-
ing. They work much faster than a human mind and the
complexity of the things they can learn is expanding over
time. Another important feature that makes ML a reli-
able tool is its cost, when an algorithm is created and
the data set is gathered the cost of implementing it is
very low compared to other research tools. So the main
cost of machine learning is gathering enough data for the
algorithm to be efficient, in the present study the data
depends on the technique used to gather it, as different
techniques have different costs.
The aim of this project is to implement a ML algorithm
to study a set of CAFs and fibroblasts from healthy pa-
tients and train the algorithm to differentiate them. We
are studying the cytoskeleton of the cells using two differ-
ent techniques, both study a set of morphological param-
eters obtained by observing the actin protein of the cells
with florescence [5]. In one case the cell sample has been
obtained from people, affected by cancer, and people who
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simply donated some breast cells due to some control or
breast reduction. In the other case a sample of cells have
been modified with TGF (transforming growth factor,
[8]) drugs in order to activate the fibroblasts, artificially.
We believe that if we succeed on proving this algo-
rithms useful, it should be very helpful for cancer diag-
nosis, as this algorithm should be able to study cells from
apparently healthy patients and detect the probability of
them suffering from, otherwise undetected, breast can-
cer. But it will also be useful to reach relevant biomedi-
cal conclusions, for instance which parameters are likely
to be more relevant in the spread of cancerous cells and
therefore which parameters should research highlight.
During the following sections the data used and the
applied method are going to be discussed. And we aim
to reach some relevant conclusions that help the scientific
community in the fight against breast cancer.
II. THE DATA SET
During the study two different sets of data were used.
One set of data was obtained by observing a group of
17004 single cells from 24 different people. The sam-
ple was given by the Breast Cancer Now Tissue Bank,
[7]. The cytoskeleton of each cell was observed and
parametrized with 14 parameters. In order to draw the
structure of the cytoskeleton a chemical that reacted to
the proteins of actin was used. For further information
about this process I recommend the cited article, [5].
The other data set was studied the same way but the
sample came from a group of artificially modified cells
only from healthy patients. The size of this data set is
considerably small, with only 3570 studied cells, from
only 6 different people.
The data from the 24 patients was divided in 12
batches. Each batch contained cells of one healthy pa-
tients (a total of 12) and one patient that suffered breast
cancer (a total of 12). From the patients that have suf-
fered from cancer 4 different cancer types were studied,
as listed in Table I. The age range studied in this study
goes from 20 to 84 years old.
Depending on the location of the studied cell a 15th
parameter was added, if the cell came from a healthy pa-
tient we considered a non-activated fibroblasts; if the cell
came from an affected patient the cells were labelled with
an S if it came from the tissue surrounding the tumour
(although apparently healthy) or a T if it came from the
affected tissue (therefore we considered this, activated fi-
broblasts). The number of cells in each group for each set
of data is: 5807: N/ 5645: S/ 5552: T; actin fluorescence
microscopy . And 1290: N/ 1161: S/ 1119: T; for the
data obtained with TGF modified cells.
In order to standardise all the data, and evaluate it all
with the same scale some modifications were performed
before the study. A normalisation of every parameter
Batch Cancer Type Ages
1 Luminal A 28/84
2 Her2 enriched 52/54
3 Luminal B 25/48
4 Triple Negative 34/44
5 Her2 enriched 20/42
6 Luminal A 40/36
7 Luminal A 31/39
8 Luminal A 55/75
9 Lumnial A 48/47
10 Luminal A 57/47
11 Triple Negative 20/34
12 Triple Negative 65/48
TABLE I: Ages (healthy patient/cancer affected patient) and
cancer types of each batch. Only the healthy patients from
batches 7,8 and 9 were used in the study with tgf activated
fibroblasts.





After doing this normalisation we plotted an histogram
for each parameter in each group (N/S/T), in order to
observe if any of the parameters clearly drew a different
behaviour for CAFs, none did.
In order to increase the efficiency of the algorithm we






Where x is the raw score, µ is the parameter mean, and
σ is the standard deviation. It is a very useful standard
score as it yields how far away the value is from the mean
value.
A. Training and testing the algorithm
A key factor when it comes to machine learning is the
set of data we use for the training. In this project the
data was divided randomly,a random 5% of the data was
used to test the results and the remaining 95% was used
to train the algorithm. However, in order to avoid the
randomness affecting the results, we have implemented
the algorithm over 10 times and calculated the average
results.
As there are 24 patients we were concerned that the
correlation between cells of a same patient would affect
the results. So that the algorithm would base its decision
on detecting the patient, not the activation of fibroblasts.
In order to ensure that wasn’t the case we tried the algo-
rithm using 11 batches as the training set and only one
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batch to test the result, we did that for with every batch.
We did observe a decrease in the accuracy of the algo-
rithm, but it can be associated with the decline of the
training size.
Even though we found that the correlation in a pa-
tient data is not relevant we observed something inter-
esting when testing the algorithm with each batch. We
observed that the accuracy among the healthy cells is
similar (around a 70%), in every batch. However the
accuracy in the affected tissue decreases a lot in some
batches, probably this is related with the number of non-
activated fibroblasts in the extirpated tissue.
III. THE ALGORITHM
With a proper data set we needed to find the most suit-
able algorithm to study it. We studied 3 algorithms that
were likely to be suitable and tried to find which was
the one with the best performance. We also observed
how long it took for them to run and how variant they
were. The three algorithms perform supervised learning,
and are used for classification. Supervised learning oc-
curs when a set of example data and associated target
responses (in this case healthy cell or tumour associated
cell) are studied by the algorithm to later predict the
correct response when posed with new examples.
We used classification algorithms from the library
Sckit Learn, in python. We considered three of the algo-
rithms given of this library, tried them and timed their
performance. The results obtained with the first data
set are listed in TABLE II. The results obtained with
the other data set are listed in TABLE III
Algorithm Performance Time (s) CoV (%)
RFC (80) 0.73 0.51 1,4
Neural Network 0.69 1.07 2,0
SVC 0.70 0.31 1,8
TABLE II: List of all the algorithms that were tested, RFC
(Random Forest Classification), Neural Networks and Sup-
port Vector Machines (SVM). The performance listed refers
to the probability for the algorithm to reach the right answer.
The number 80 in the parenthesis is the number of decision
trees used to obtain this result, for further understanding see
following sub section.
Algorithm Performance Time (s) CoV (%)
RFC (74) 0.69 0.31 2,9
Neural Network 0.67 0.73 5
SVC 0.65 0.15 3,2
TABLE III: Results for the data set from artificially modified
cells. The number 74 in the parenthesis is the number of
decision trees used to obtain this result.
The Random Forest Classification (RFC) and Support
Vector Machines (SVM) were considered the best to use
for the study. Deciding to use Random Forest Classifi-
cation in the end as the performance was slightly better
and the size of the data set isn’t long enough to notice the
time difference. For future studies with larger datasets
i would recommend to reconsider using an SVM algo-
rithm, or any other algorithm that would present it self
more efficient than RFC.
Notice that the results for the second data set are
slightly less precise, however as the data set is much
smaller the time inverted is shorter. Therefore this data
can be considered better than the data obtained by fluo-
rescence as it gives more information per cell. We believe
that the difference between both data sets lies in the fact
that in tumour affected tissue not all fibroblasts are acti-
vated, however in the artificially activated fibroblasts the
percentage of CAFs is higher, and so it is the efficiency of
training the algorithm. The last elements in the Tables
II and III, referred to as Coefficient of Variance (CoV),
is the standard deviation divided by the accuracy, it is
an indicator of the spread of the results, and thus how
much randomness affects the algorithm.
A. The Random Forest Classification algorithm:
The RFC is a classification algorithm based on deci-
sion trees. The algorithm generates N decision trees,
each tree reaches a decision and classifies the input, then
the algorithm uses averaging to improve the predictive
accuracy. A number of statistical measurements deter-
mine how to make the splits in each decision tree. When
we train the algorithm with a training dataset that has
been already classified this splits are modified and grow
the accuracy of the decision trees.
Obviously the more trees the algorithm uses the more
accurate the result will be, but it will also take more
time to run it. That is why we must study the accuracy
of the algorithm versus the number of trees in order to
optimise it. That is exactly what was done, in fig.1 we
show the results obtained. As it can be seen in the figure
the optimal number of trees is above 60 and below a
100, as above a 100 trees the accuracy of the algorithm
plateaus and grows very slowly, making it is worthless to
grow the number of trees anymore.
As it has been already stated there is a randomness
associated with the results, but using 80 decision trees
the accuracy is estimated around a 73% using the RFC
algorithm.
IV. THE STUDY OF THE PARAMETERS
Another important point for the optimisations of the
algorithm is to study what parameters are more impor-
tant for the algorithm to classify data, we could see that
some parameters are crucial and some are less relevant or
even misleading. Furthermore studying the relevance of
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FIG. 1: Figure showing the accuracy of the algorithm vs the
number of decision trees used to make the decision. This
results concern the data obtained by using actin fluorescence
microscopy.
the parameters for the classification might also rise some
biomedical conclusions. Nevertheless it is important to
take in mind that correlation and causation are not syn-
onyms. That is why the results obtained in this section
must be further studied in order to verify a causal rela-
tion between the relevant parameters and the activity of
the fibroblasts.
In order to arrange the importance of each parameter
we observed how the accuracy of the algorithm varied
with and without each parameter. The parameter con-
sidered less relevant was removed from the matrix of pa-
rameters and the other parameters were further studied.
We repeated this step 12 times, leaving only the 2 most
important parameters left. We expected the curve to
grow very fast at first, with only 2 parameters it is very
difficult for it to achieve a good result. We expected this
curve to grew very fast as the most important parameters
were included in the data and to stop growing afterwards.
Finally, some of the parameters might be misleading and
so might cause a decrease in the accuracy.
In figures 2 and 3 the results obtained by this process
can be observed.
The first figure refers to the results obtained with un-
modified cells. The order of appearance of the parame-
ters is as follows: ’Length variation’,’Alignment’, ’Fibre
length’, ’Aspect ratio’, ’Peak’, ’Curvature’, ’F-actin total
amount’, ’Spread’,’Thickness var’, ’Stellate factor’, ’Chi-
rality’, ’Chirality var’. The parameters that were left in
the data set were: ’Area’ and ’Fibre thickness’.
In the second case, concerning the TGF modified cells,
the results were as follows: ’Alignment’, ’Fibre thickness’,
’Stellate factor’, ’Length variation’ , ’Chirality var’, ’Cur-
vature’, ’Spread’, ’Peak’, ’F-actin total amount’, ’Aspect
ratio’ ,’Thickness var’, ’Chirality’. The parameters that
were left in the data set were: ’Area’ and ’Fibre length’.
We ran the code to create this figures more than once,
and there was a high variation on the order of the last
group of parameters, however, we could expect this varia-
tion we can not observe a change in the curve’s behaviour
FIG. 2: In this figure we can observe the evolution of the
accuracy of the parameters when taking of the most relevant
parameters. Shown data: mean± SD, with N= 50 iterations
FIG. 3: Results for the artificially modified cells. Shown data:
mean± SD, with N= 100 iterations.
with the removal of this parameters (they seem to be
quite useless when it comes to decide whether or not the
cell is affected), in the second figure we can observe even
a decrease in the accuracy which would indicate that this
parameters might be misleading.
V. CONCLUSIONS
With this study we were able to establish a correla-
tion between a set of parameters of a group of fibroblasts
and the presence of cancerous cells. We have written an
algorithm capable of detecting this correlation and clas-
sifying this cells as cancer associated, although the ac-
curacy of its classification could be improved in further
studies. Moreover we observed that not all parameters
are equally relevant, a further study on this parameters
and their relation to cancerous cells, maybe by modifying
this parameters with the use of drugs, could help curing
the illness. Or rather stop it in earlier stages avoiding its
growth and spread. Again, this must be further studied
medically, the contribution of this study is showing the
correlations between parameters and cancerous tissue.
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The parameter that was demonstrated the most rel-
evant was the Area of the cell’s cytoskeleton, however
some other parameters were relevant in both samples,
for example the fibre morphology seams to affect the de-
cision very much. Some other parameters do not have
any relevance in the decision making, maybe we could
remove them from further observations, it would make
the code more efficient and we wouldn’t have to assume
the cost of measuring those parameters.
Given the results shown in the previous sections the
probability of detecting CAFs as single cells is not high
enough as to assure that the patient has cancer by only
studying one cell, we consider a 73% of accuracy a low
value. Nevertheless, as the studied set of data shows,
we study many cells of every patient accordingly we en-
courage the study of samples of cells from every patient
for an accurate diagnosis rather than the study of single
cells. As we have already discussed the cells we study
have to be within the tumour, as the surrounding tissue
is not affected enough as to detect a relevant presence of
CAFs.
The fact that we need a big sample of affected tissue is
a little discouraging as it means that this algorithm is not
a good tool to detect cancer in earlier stages, as we have
to locate the tumour and extirpate some affected tissue
to run the algorithms, without locating the algorithm we
can not detect cancerous cells. However the idea of using
ML to diagnose cancer can be used in other fields, such as
day-to-day habits that are correlation to the apparition
of cancer (such as smoking or doing sport), genetic his-
tory, or even a combination of all this different data sets.
This algorithm can be useful once the cancer has been
diagnosed, in order to confirm it, or given the case to
detect what kind of cancer the patient is suffering. With
a bigger data set this classification could be performed
with a similar algorithm.
Concerning the study of cell groups we consider that
trying other algorithms such as Support Vector Machines
(SVM) would be very interesting, as despite the decrease
in the accuracy, the efficiency of the algorithm would
probably increase significantly. Besides adding data to
the sample will rise the time of computing, thus a faster
algorithm will be better to run a bigger data set, and the
accuracy of the algorithm should improve significantly.
Every data set has different properties and we must al-
ways find the most suitable algorithm for each data set,
depending on its features and our propose.
Another possible further research concerns the fact
that fibroblasts are not always cancer-promoting cells.
Despite it is true that they play a main role in the growth
and spread of the tumour, they can also be healing and
cancer-suppressing. If we were able to compare this two
groups of fibroblasts and differentiate them as we did be-
tween healthy and affected tissue, we might reach new
conclusions. Knowing what parameters of an activated
fibroblast we must affect to turn it from cancer promot-
ing to cancer suppressing could be a key step to cure
it.
During this study we haven’t been able to create an
effective tool for diagnosing cancer in very early stages,
however we have created an algorithm that sets a seed
in the direction of using what ML can offer in order to
improve and make research more efficient. Furthermore,
we have observed various parameters that are correlated
with cancer and have pointed out which ones are more
important to differentiate whether a cell is likely to be in
a tumour affected tissue or not, this information is useful
for further research on how to suppress CAFs by, maybe,
modifying some of this parameters.
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